{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:01:56Z","timestamp":1785726116524,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"College of Veterinary Medicine, Lincoln Memorial University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.schres.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T07:01:31Z","timestamp":1566111691000},"page":"107-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Targeted lipidomics and metabolomics evaluations of cortical neuronal stress in schizophrenia"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-9936","authenticated-orcid":false,"given":"Paul L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.08.003_bb0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.psychres.2017.11.003","article-title":"Do cognitive deficits predict negative emotionality and aggression in schizophrenia?","volume":"259","author":"Ahmed","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A","article-title":"The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation","volume":"45","author":"Becker","year":"1996","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0015","doi-asserted-by":"crossref","first-page":"29156","DOI":"10.1074\/jbc.M110.111765","article-title":"Molecular characterization of N-acetylaspartylglutamate synthetase","volume":"285","author":"Becker","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.schres.2019.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/wnl.18.11.1140","article-title":"Adult metachromatic leukodystrophy (sulphatide lipidosis) simulating acute schizophrenia. Report of a case","volume":"18","author":"Betts","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2019.08.003_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-1154-7_12","article-title":"Role of galactosylceramide and sulfatide in oligodendrocytes and CNS myelin: formation of a glycosynapse","volume":"9","author":"Boggs","year":"2014","journal-title":"Adv Neurobiol."},{"key":"10.1016\/j.schres.2019.08.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2009.11.074","article-title":"Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes","volume":"584","author":"Boggs","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.schres.2019.08.003_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.euroneuro.2012.07.007","article-title":"Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-\u03b1 gene (PPARA) and schizophrenia","volume":"23","author":"Costa","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2019.08.003_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12035-008-8022-3","article-title":"The role and metabolism of sulfatide in the nervous system","volume":"37","author":"Eckhardt","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.schres.2019.08.003_bb0045","article-title":"Relationship between neuropsychological behavior and brain white matter in first-episode psychosis","volume":"13","author":"Faria","year":"2019","journal-title":"Schizophr Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2009.03.038","article-title":"Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia","volume":"111","author":"Ghose","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0055","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/appi.ajp.2009.08091445","article-title":"Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?","volume":"166","author":"Ghose","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2019.08.003_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2012.09.032","article-title":"Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients","volume":"530","author":"Gilabert-Juan","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2019.08.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101781","article-title":"Altered frontal white matter asymmetry and its implications for cognition in schizophrenia: a tractography study","volume":"22","author":"G\u00f3mez-Gastiasoro","year":"2019","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.schres.2019.08.003_bb0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1096\/fj.05-5362com","article-title":"Non-targeted profiling of lipids during kainate-induced neuronal injury","volume":"20","author":"Guan","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.schres.2019.08.003_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1471-4159.1997.69020753.x","article-title":"Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons","volume":"69","author":"Hansen","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.schres.2019.08.003_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1471-4159.2000.0750861.x","article-title":"Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons","volume":"75","author":"Hansen","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.schres.2019.08.003_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-4159.2001.00006.x","article-title":"Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death","volume":"76","author":"Hansen","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.schres.2019.08.003_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.schres.2019.08.003_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2012.11.027","article-title":"NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test","volume":"701","author":"Janczura","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2019.08.003_bb0100","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.11-201152","article-title":"2012. Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia","volume":"26","author":"Janfelt","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.schres.2019.08.003_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/schbul\/sbr127","article-title":"N-Acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia","volume":"39","author":"Jessen","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.08.003_bb0110","article-title":"Changes in N-acylethanolamine pathway related metabolites in a rat model of cerebral ischemia\/reperfusion","volume":"1","author":"Kilaru","year":"2011","journal-title":"J.\u00a0Glycomics Lipidomics"},{"key":"10.1016\/j.schres.2019.08.003_bb0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40263-018-0539-z","article-title":"Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention","volume":"32","author":"Leweke","year":"2018","journal-title":"CNS Drugs."},{"key":"10.1016\/j.schres.2019.08.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep21873","article-title":"Prefrontal NAA and Glx levels in different stages of psychotic disorders: a 3T 1H-MRS study","volume":"6","author":"Liemburg","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2019.08.003_bb0125","doi-asserted-by":"crossref","first-page":"16693","DOI":"10.1074\/jbc.M111.230136","article-title":"N-Acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate","volume":"286","author":"Lodder-Gadaczek","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.schres.2019.08.003_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/BJ20130300","article-title":"Vesicular uptake of N-acetylaspartylglutamate is catalysed by sialin (SLC17A5)","volume":"454","author":"Lodder-Gadaczek","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.schres.2019.08.003_bb0135","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/s41598-018-25088-2","article-title":"Membrane depolarization and aberrant lipid distributions in the neonatal rat brain following hypoxic-ischaemic insult","volume":"8","author":"Luptakova","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2019.08.003_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2013.06.013","article-title":"Quantification of endocannabinoids in postmortem brain of schizophrenic subjects","volume":"148","author":"Muguruza","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nlm.2019.01.006","article-title":"A\u00a0role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition","volume":"158","author":"Neale","year":"2019","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.schres.2019.08.003_bb0150","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-4159.2004.02358.x","article-title":"NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR","volume":"89","author":"Olszewski","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.schres.2019.08.003_bb0155","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/tp.2012.68","article-title":"NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia","volume":"2","author":"Olszewski","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2019.08.003_bb0160","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s11064-017-2181-4","article-title":"NAAG peptidase inhibitors act via mGluR3: animal models of memory, Alzheimer's, and ethanol intoxication","volume":"42","author":"Olszewski","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mrm.21820","article-title":"Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy","volume":"61","author":"Pearce","year":"2009","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.schres.2019.08.003_bb0170","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1209934109","article-title":"Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis","volume":"109","author":"Rahn","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2019.08.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131861","article-title":"Selective CNS uptake of the GCP-II inhibitor 2-PMPA following intranasal administration","volume":"10","author":"Rais","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2019.08.003_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1096\/fj.06-6919com","article-title":"A\u00a0peroxisomal acyltransferase in mouse identifies a novel pathway for taurine conjugation of fatty acids","volume":"21","author":"Reilly","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.schres.2019.08.003_bb0185","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/schbul\/sbs092","article-title":"In vivo measurements of glutamate, GABA, and NAAG in schizophrenia","volume":"39","author":"Rowland","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.08.003_bb0190","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1021\/bi0608008","article-title":"A\u00a0FAAH-regulated class of N-acyl taurines that activates TRP ion channels","volume":"45","author":"Saghatelian","year":"2006","journal-title":"Biochemistry."},{"key":"10.1016\/j.schres.2019.08.003_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.schres.2019.08.003_bb0200","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/pr800188y","article-title":"High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides","volume":"7","author":"Schwarz","year":"2008","journal-title":"J.\u00a0Proteome Res."},{"issue":"35","key":"10.1016\/j.schres.2019.08.003_bb0205","first-page":"215","article-title":"Association of polymorphisms of NAPE-PLD and FAAH genes with schizophrenia in Chinese Han population","volume":"10","author":"Si","year":"2018","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"10.1016\/j.schres.2019.08.003_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0278-5846(88)90065-6","article-title":"Sialic acid in platelets of schizophrenic patients","volume":"12","author":"Sirota","year":"1988","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2019.08.003_bb0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1471-4159.2011.07305.x","article-title":"Detection of N-acetyl methionine in human and murine brain and neuronal and glial derived cell lines","volume":"118","author":"Smith","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.schres.2019.08.003_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2010.11.048","article-title":"Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice","volume":"1371","author":"Takatsu","year":"2011","journal-title":"Brain Res."},{"issue":"10 Suppl","key":"10.1016\/j.schres.2019.08.003_bb0225","first-page":"29","article-title":"Glutamate pharmacology and the treatment of schizophrenia: current status and future directions","volume":"3","author":"Tamminga","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.08.003_bb0230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0300-9084(03)00047-6","article-title":"Salvage pathways in glycosphingolipid metabolism","volume":"85","author":"Tettamanti","year":"2003","journal-title":"Biochimie."},{"key":"10.1016\/j.schres.2019.08.003_bb0240","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/bi702530z","article-title":"Oxidative metabolism of a fatty acid amide hydrolase-regulated lipid, arachidonoyltaurine","volume":"47","author":"Turman","year":"2008","journal-title":"Biochemistry."},{"key":"10.1016\/j.schres.2019.08.003_bb0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pcn.12823","article-title":"Glutamate hypothesis in schizophrenia","volume":"73","author":"Uno","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2019.08.003_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/325789","article-title":"Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study","volume":"2011","author":"Uranova","year":"2011","journal-title":"Schizophr. Res. Treatment."},{"key":"10.1016\/j.schres.2019.08.003_bb0255","article-title":"Accumulation of N-acylphosphatidylserines and N-acylserines in the frontal cortex in schizophrenia","volume":"1","author":"Wood","year":"2014","journal-title":"Neurotransmitter (Houst)"},{"key":"10.1016\/j.schres.2019.08.003_bb0260","series-title":"Springer Protocols, Neuromethods: Lipidomics","first-page":"13","article-title":"Non-targeted lipidomics utilizing constant infusion high resolution ESI mass spectrometry","volume":"125","author":"Wood","year":"2017"},{"key":"10.1016\/j.schres.2019.08.003_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.schres.2015.05.017","article-title":"Dysfunctional glycosynapses in schizophrenia: disease and regional specificity","volume":"166","author":"Wood","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0270","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.schres.2014.08.029","article-title":"Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72\/G30 transgenic mouse","volume":"159","author":"Wood","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.003_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.csbj.2016.02.003","article-title":"Metabolomic profiling of post-mortem brain reveals changes in amino acid and glucose metabolism in mental illness compared with controls","volume":"14","author":"Zhang","year":"2016","journal-title":"Comput Struct Biotechnol J."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:29:38Z","timestamp":1760297378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419303433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":54,"alternative-id":["S0920996419303433"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.08.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted lipidomics and metabolomics evaluations of cortical neuronal stress in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}